Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive CofiledCriticalColgate Palmolive Co
Priority to CO93423052ApriorityCriticalpatent/CO4230014A1/en
Publication of CO4230014A1publicationCriticalpatent/CO4230014A1/en
UNA COMPOSICION ORAL QUE COMPRENDE UN VEHICULO LIQUIDOADECUADO PARA CONTACTAR TOPICAMENTE SUPERFICIES DENTALES Y ENCIAS Y COMO UN AGENTE ANTIPLACA, HASTA ALREDEDOR DEL 20% EN PESO BASADO SOBRE EL PESO TOTAL DE LA COMPOSICION DE N-METILPIRROLIDONA COMO AGENTE ANTIPLACA.LA COMPOSICION ORAL DE UNA CUALQUIERA DE LAS REIVINDICACIONES 1 A 4 QUE COMPRENDE ADICIONALMENTE UN AGENTE ANTIBACTERIAL NO CATIONICO SOLUBLE EN AGUA.1LA COMPOSICION ORAL DE LA REIVINDICACION 5 QUE COMPRENDE ADICIONALMENTE UN AGENTE MEJORADOR ANTIBACTERIAL CATIONICO, DONDE LA CANTIDAD DEL AGENTE ANTIBACTERIAL CATIONICO ES DE ALREDEDOR DEL 0.001 AL 15% EN PESO.AN ORAL COMPOSITION COMPRISING A LIQUID VEHICLE SUITABLE TO CONTACT TOPICALLY DENTAL SURFACES AND GUMS AND AS AN ANTI-PLAQUE AGENT, UP TO AROUND 20% IN WEIGHT BASED ON THE TOTAL WEIGHT OF THE COMPOSITION OF N-METHYLPIRROLIDONE AS AN AGENT COMPOSITION OF CLAIMS 1 TO 4 ADDITIONALLY INCLUDING A NON-CATIONIC ANTIBACTERIAL AGENT SOLUBLE IN WATER. WEIGHT.
CO93423052A1993-12-161993-12-16
N-METHYLPYROLIDONE BASED ORAL COMPOSITION
CO4230014A1
(en)
PHARMACEUTICAL COMPOSITION WITH ANESTHETIC EFFECT, USE OF THIS COMPOSITION FOR THE MANUFACTURE OF MEDICINES, AND PROCESS FOR THE MANUFACTURE OF THIS COMPOSITION.
A DERMATOLOGICAL OR COSMETIC COMPOSITION THAT INCLUDES AN AMOUNT OF EFFECTIVE SPHINGOMYELINASE TO PRODUCE AN INCREASE IN THE LEVEL OF SKIN AND MUCOUS CERAMIDES.
EMULSIONABLE COMPOSITION FOR THE REPRESSION OF INSECTS, WHICH IS DERIVED FROM THE TYPE OF PHENYLPIRAZOLS REPLACED IN POSITION 1, AND DO NOT FAVOR THE FORMATION OF CRYSTALS
PHARMACEUTICAL COMPOSITIONS, FOR TOPICAL USE, CONTAINING OXYGEN-FREE DIRADICAL "SCAVENGERS" AND ANTIBACTERIALS, INDICATED IN THE THERAPY OF SURFACE TISSUES